Functional Brain Age Measurement In Children And Adolescents
Funder
National Health and Medical Research Council
Funding Amount
$700,433.00
Summary
An important aspect of medicine is measuring the function of the human body. It is often advantageous to convert complex functional measures into simpler, intuitive measures such as 'age'. We can compare functional age to chronological age to diagnose disease. In this project, we will build an estimate of 'brain age' in children and adolescents using recordings of the electrical activity of the brain. We will test this 'brain age' as a diagnostic tool in several neurological disorders.
Bringing Fields Together: Identifying Individuals At Risk Of Eating Disorders In Weight Management Programs
Funder
National Health and Medical Research Council
Funding Amount
$594,144.00
Summary
A major barrier in improving obesity and eating disorder care is the hotly debated issue of eating disorder risk following weight management. Using 'big data' methods and international collaborations, we will analyse individual-level data from weight management trials with eating disorder assessments, and deconstruct these complex interventions into their smallest 'active ingredients'. We will translate findings into recommendations so that treatment approaches can be tailored to individuals.
Understanding Sex Differences In Alcohol Use Disorder: The Role Of Stress And Neuropeptides
Funder
National Health and Medical Research Council
Funding Amount
$692,106.00
Summary
Alcohol use disorders (AUD) are an emerging issue in women, yet there is little understanding of the how the male and female brains differ in response to excessive alcohol consumption. In pilot studies, we have found that deletion of a specific brain chemical causes differences in the way male and female mice consume alcohol in excess. We will further characterise this system and test new approaches to reduce the desire to consume alcohol.
ARX- A Hub Gene For A Common Biological Pathway In Schizophrenia
Funder
National Health and Medical Research Council
Funding Amount
$707,974.00
Summary
Schizophrenia is a severe psychiatric disorder with no cure. I have identified that some people with schizophrenia show variations to a gene called ARX. This project will use preclinical mouse models to explore how variations to the Arx gene affect brain molecules, networks of cells and behavioural outcomes. This biological pathway will provide the framework for the identification of new molecules to target therapeutically to modify the biological course of schizophrenia and improve outcomes.